Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Piper Sandler Maintains Underweight on Tyson Foods, Lowers Price Target to $79

Piper Sandler Maintains Underweight on Tyson Foods, Lowers Price Target to $79

Piper Sandler analyst Michael Lavery maintains Tyson Foods (NYSE:TSN) with a Underweight and lowers the price target from $85 to $79.

byBenzinga Newsdesk

July 1, 2022

1 minute read

Piper Sandler analyst Michael Lavery maintains Tyson Foods (NYSE:TSN) with a Underweight and lowers the price target from $85 to $79.

RBC Capital Maintains Outperform on Samsara, Raises Price Target to $19

By Benzinga Newsdesk

February 27, 10:18 AM

RBC Capital analyst Matthew Hedberg maintains Samsara (NYSE:IOT) with a Outperform and raises the price target from $15 to $19.

IOT

Ocular Therapeutix Q3 EPS $(0.31) Misses $(0.24) Estimate, Sales $11.91M Miss $14.27M Estimate

By Michael Horton

November 7, 5:05 PM

Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.24) by 29.17 percent. This is a 34.78 percent decrease over losses of $(0.23) per share

OCUL

Analyst Ratings

What 6 Analyst Ratings Have To Say About Nutanix

By Benzinga Insights

October 11, 5:56 PM

Within the last quarter, Nutanix (NASDAQ:NTNX) has observed the following analyst ratings:

NTNX

JMP Securities Maintains Market Outperform on Mid-America Apartment, Raises Price Target to $190

By Benzinga Newsdesk

February 3, 7:45 AM

JMP Securities analyst Aaron Hecht maintains Mid-America Apartment (NYSE:MAA) with a Market Outperform and raises the price target from $180 to $190.

MAA

Piper Sandler Maintains Underweight on Tyson Foods, Lowers Price Target to $79

Related Posts

RBC Capital Maintains Outperform on Samsara, Raises Price Target to $19

Ocular Therapeutix Q3 EPS $(0.31) Misses $(0.24) Estimate, Sales $11.91M Miss $14.27M Estimate

What 6 Analyst Ratings Have To Say About Nutanix

JMP Securities Maintains Market Outperform on Mid-America Apartment, Raises Price Target to $190